Literature DB >> 3716788

Pigmented villonodular synovitis. A clinicopathologic study of 52 cases.

M Ushijima, H Hashimoto, M Tsuneyoshi, M Enjoji.   

Abstract

Clinicopathologic, enzyme histochemical and electron microscopic findings in 52 patients with pigmented villonodular synovitis (PVS) are reported. The lesion was by far the most common in the knee joint (48%), followed by the ankle joint (25%). As to sex incidence, there seemed to be no predilection (46% in men, 54% in women). Microscopically, the PVS showed thin or thick villous projections of the involved synovial membrane, associated with or without nodular formation. The nodule of PVS consisted essentially of a proliferation of histiocyte-like cells with phagocytic activities. Another characteristic feature was large clefts and pseudoglandular or alveolar spaces lined by synovial cells. Enzyme histochemical studies revealed that the lesional cells had functional properties of macrophages. Electron microscopically, the lesion consisted essentially of histiocyte-like and fibroblast-like cells, together with intermediate cells and myofibroblasts.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3716788     DOI: 10.1111/j.1440-1827.1986.tb01022.x

Source DB:  PubMed          Journal:  Acta Pathol Jpn        ISSN: 0001-6632


  2 in total

1.  Magnetic resonance imaging and thallium-201 scintigraphy for the diagnosis of localized pigmented villonodular synovitis arising from the elbow: A case report and review of the literature.

Authors:  Kazutaka Koto; Hiroaki Murata; Tomoya Sakabe; Takaaki Matsui; Naoyuki Horie; Yasushi Sawai; Yoshiro Tsuji; Toshikazu Kubo
Journal:  Exp Ther Med       Date:  2013-03-21       Impact factor: 2.447

2.  LOCALIZED PIGMENTED VILLONODULAR SYNOVITIS: CASE REPORT.

Authors:  Fabiola Andrea de Carvalho Godoy; Carlos Alberto Cury Faustino; Cláudio Santos Meneses; Sergio Tadao Nishi; César Eduardo Giancoli Góes; Abaeté Leite do Canto
Journal:  Rev Bras Ortop       Date:  2015-11-17
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.